Integrating partnerships and collaborations into our core business strategy
Connect with us
To explore partnership opportunities, please contact firstname.lastname@example.org
Working with great partners and collaborators forms a core part of our corporate strategy, and allow us to expand and accelerate our efforts to bring novel multifunctional therapeutics to the broadest group of patients in the most efficient manner possible.
Our partnerships and collaborations focus on:
- Development and commercialization of current and future product candidates
- Clinical and research collaborations that broaden the potential of our internal Antibody-Drug Conjugate (ADC) and Multispecific Antibody Therapeutics (MSAT) platforms
- Collaborations with early-stage companies to access technologies and programs that are complementary to our internal ADC and MSAT capabilities